Pol ι activates G6PD through OGT-mediated G6PD O-GlcNAcylation, and inhibition of G6PD activity by the specific inhibitor polydatin attenuates Pol ι-promoted ESCC cell proliferation both in vitro and in vivo. This evidence concerns the gene G6PD and esophageal squamous cell carcinoma.